A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 μg per day) for the treatment of patients with mild-to-moderate asthma

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 4 I, 1998, Pages 433-438

  Bernstein, David I ^a,g   Cohen, Robert ^b   Ginchansky, Elliot ^c   Pedinoff, Andrew J ^d   Tinkelman, David G ^e   Winder, John A ^f  

^a Bernstein Clinical Research Center   (United States)

^b Allergy and Asthma Center   (United States)

^c Allergy and Asthma Specialists   (United States)

^d Princeton Allergy/Asthma Research   (United States)

^e Allergy and Asthma of Atlanta   (United States)

^f Allergy and Asthma Research Center of Toledo   (United States)

^g Division of Immunology   (United States)

Author keywords

Asthma; Inhaled corticosteroid; Triamcinolone

Indexed keywords

PLACEBO; SALBUTAMOL; TRIAMCINOLONE;

ADULT; ALLERGIC DISEASE; ARTICLE; ASTHMA; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; SPIROMETRY;

EID: 0031959158     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(98)70349-5     Document Type: Article

References (26)

1. Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report; March 1993. Washington (DC): National Institutes of Health; National Heart, Lung, and Blood Institute; January 1995. National Institutes of Health publication NIH 95-3659.
2. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
3. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704.
4. Laitinen LA, Laitinen A. Airway morphology: epithelium/basement membrane. Am J Respir Crit Care Med 1994;150(suppl):S14-7.
5. Joint Task Force on Practice Parameters. Practice parameters for the diagnosis and treatment of asthma. J Allergy Clin Immunol 1995;96(suppl):797-8.
6. Guidelines for the management of asthma: a summary. Br Med J 1993;306:776-82.
7. Barnes PJ. Molecular mechanisms of steroid action in asthma. J Allergy Clin Immunol 1996;97(suppl):159-68.
8. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995;332:868-75.
9. Haahtela, Jarvinen M, Kava T, Kivaranta K, Koskinen S, Lehtonen K, et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-92.
10. Haahtela T, Jarvinen M, Kava T, Kivaranta K, Koskinen S, Lehtonen K, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-5.
11. Zora JA, Lutz CN, Tinkelman DG. Assessment of compliance in children using inhaled beta adrenergic agonists. Ann Allergy 1989; 62:406-9.
12. Mawhinney H, Spector SL, Kinsman RA, Siegel SC, Rachelefsky GS, Katz RM, et al. Compliance in clinical trials of two non-bronchodilator, antiasthma medications. Ann Allergy 1991;66: 294-9.
13. Sbarbaro JA, Steiner JF. Noncompliance with medications: vintage wine in new (pill) bottles [editorial]. Ann Allergy 1991;66:273-5.
14. Rand CS, Wise RA, Nides M, Simmons MS, Bleecker ER, Kusek JW, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992;146:1559-64.
15. Chmelik F, Doughty A. Objective measurements of compliance in asthma treatment. Ann Allergy 1994;73:527-32.
16. Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin DP. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest 1996;109:963-8.
17. Mann MC, Eliasson O, Patel K, ZuWallack RL. An evaluation of severity-modulated compliance with q.i.d. dosing of inhaled beclomethasone. Chest 1992;102:1342-6.
18. Williams MH Jr, Kane C, Shim CS. Treatment of asthma with triamcinolone acetonide delivered by aerosol. Am Rev Respir Dis 1974;109:538-43.
19. Bernstein IL, Chervinsky P, Falliers CJ. Efficacy and safety of triamcinolone acetonide aerosol in chronic asthma. Results of a multicenter, short-term controlled and long-term open study. Chest 1982;81:20-6.
20. Falliers CJ, Petraco AJ. Control of asthma with triamcinolone acetonide aerosol inhalations at 12-hour intervals. J Asthma 1982;19:241-7.
21. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993;93:64-77.
22. Chervinsky P, van As A, Bronsky EA, Dockhorn R, Noonan M, LaForce C, et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J Allergy Clin Immunol 1994;94:676-83.
23. Busse WW. Dose related efficacy of Pulmicort® (budesonide) Turbuhaler® in moderate to severe asthma [abstract]. J Allergy Clin Immunol 1994;93:186.
24. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992;90:32-42.
25. Dukes MNG, Holgate ST, Pauwels RA. report of an international workshop on risk and safety of asthma therapy. Clin Exp Allergy 1994;24:160-5.
26. Toogood JH, Baskerville JC, Jennings B, Lefcoe NM, Johansson SA. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 1982;70:288-98.